| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.00097 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.00083 | 1 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.00061 | 1 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.00056 | 1 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.00047 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.00032 | 1 |